Serum chemokine IL-8 acts as a biomarker for identifying COVID-19-associated persistent severe acute kidney injury

CONCLUSION: Plasma IL-8 is a promising marker for the early identification of PS-AKI among COVID-19 patients. These findings should be validated in further studies with a larger sample size.PMID:38305217 | PMC:PMC10840601 | DOI:10.1080/0886022X.2024.2311316

Source: Renal Failure - February 2, 2024 Category: Urology & Nephrology Authors: Zhi He Jing-Jing Liu Shao-Lei Ma Source Type: research